Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Painter

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Urology|October 19, 1999
1998 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of ureteral stones and impact of managed careM P O'Leary, W F Gee, H L Holtgrewe, et al.
Mbio|May 3, 2024
4'-Fluorouridine inhibits alphavirus replication and infection <i>in vitro</i> and <i>in vivo</i>Peiqi Yin, Nicholas A May, Laura Sandra Lello, et al.
Antiviral Research|September 9, 2019
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infectionGeorge R Painter, Richard A Bowen, Gregory R Bluemling, et al.
Nature Communications|July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster modelCarolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Science (New York, N.Y.)|December 2, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
The Journal of Urology|September 19, 2000
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed careM P O'Leary, W F Gee, H L Holtgrewe, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
The Journal of Urology|October 23, 1998
1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997W F Gee, H L Holtgrewe, M L Blute, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Urology|October 19, 1999
1998 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of ureteral stones and impact of managed careM P O'Leary, W F Gee, H L Holtgrewe, et al.
Mbio|May 3, 2024
4'-Fluorouridine inhibits alphavirus replication and infection <i>in vitro</i> and <i>in vivo</i>Peiqi Yin, Nicholas A May, Laura Sandra Lello, et al.
Antiviral Research|September 9, 2019
The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infectionGeorge R Painter, Richard A Bowen, Gregory R Bluemling, et al.
Nature Communications|July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster modelCarolin M Lieber, Robert M Cox, Julien Sourimant, et al.
Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
Science (New York, N.Y.)|December 2, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.
The Journal of Urology|September 19, 2000
1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed careM P O'Leary, W F Gee, H L Holtgrewe, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.
The Journal of Urology|October 23, 1998
1997 American Urological Association Gallup survey: Changes in diagnosis and management of prostate cancer and benign prostatic hyperplasia, and other practice trends from 1994 to 1997W F Gee, H L Holtgrewe, M L Blute, et al.
Pageof 19